US waives 100% tariff on select Indian specialty drugs
The United States has waived 100% tariffs on select Indian specialty drugs, according to reports. The move is expected to benefit Indian pharmaceutical manufacturers and improve trade relations between the two countries.
The tariff waiver applies to specific specialty pharmaceutical products from India. This decision reflects efforts to ease trade tensions and support the pharmaceutical sector, which is a significant component of India-US bilateral commerce.
